What do people report about CJC-1295?

What did the studies measure before people shared stories?

Small studies found that CJC-1295 raised growth hormone. They also found more insulin-like growth factor, called IGF-1. Your liver makes IGF-1 to help with growth and repair. An extra link on the DAC form makes the drug remain longer in the bloodstream. That form raised both hormones for days. The studies didn't test sleep, healing time, body fat, or clear thought. They also didn't settle long-term risks to blood sugar, the heart, or the immune system.

People describe changes they liked and changes they didn't. Their stories can't show how often a problem happens or prove a reported change came from the drug. Other concerns come from the way growth hormone acts or from public warnings. Those concerns include weak blood-sugar control, an immune reaction, and held water. Work on the drug ended before a long safety study was done.

You have short studies and personal stories, but neither gives you a long-term safety answer.

Which good and bad changes do people describe?

People using the drug for research shared the changes below. These reports did not come from a fair test with comparison groups, and no trial has checked them. The reports don't say how many people spoke up. “Most often” means a change led the reports. “Often” means fewer people mentioned it. “Now and then” means it came up less. None of those labels tells you your odds.

Changes people liked

Less soreness after training — appeared often. People say soreness faded sooner after hard sessions. Sleep and normal training could also explain the change. The reports can't sort out the cause.

Slow fat loss near the waist — appeared often. Some people describe a change over several weeks. Most also changed food or exercise. No CJC-1295 trial measured body fat.

Kept muscle while looking leaner — appeared often. Some people mention keeping muscle while eating less. They don't describe sudden growth. Food and training still cloud the cause.

More daytime energy — appeared now and then. Some people link the energy to better sleep. Others notice no change. Human trials haven't shown that the drug adds energy.

Clearer thought and focus — appeared now and then. Some people mention better focus after a few weeks. They often tie it to sleep and feeling rested. No trial found a brain change from the drug.

Skin that felt firmer or joints that felt better — appeared now and then. Some people say their skin or joints felt better. A feeling isn't the same as a change a doctor measured. Trials didn't test either result.

Deeper sleep with fewer wake-ups — appeared most often. People say they fell asleep more easily or woke less. No fair study with a comparison group found better sleep.

Changes people didn't like

Redness or soreness at the shot site — appeared often. People mention itching, swelling, redness, or pain. Most describe it as mild and brief.

A warm rush after a shot — appeared now and then. People mention brief heat, facial redness, or light-headedness. This came up more with the short form. Trials haven't measured it.

Tiredness or unusual sleepiness — appeared now and then. Some people felt tired, while others had more energy. Those opposite reports make the cause hard to place.

Headache — appeared now and then. Some people mention a mild headache that ended soon. Headaches have many causes. One report can't firmly tie a headache to the drug.

More hunger — appeared now and then. Hunger came up more when ipamorelin was used too. Ipamorelin acts on the same body system as ghrelin, the hormone that can make you hungry.

Poorer blood-sugar control — appeared now and then. Some people say blood sugar rose while growth hormones stayed high. These aren't trial results. Growth hormone can make insulin less able to lower blood sugar, so the concern matches a known effect.

Puffiness, swelling, and held water — appeared most often. Extra water led the unwanted reports. People mention swollen hands or a puffy face. Many blame the long DAC form, but their reports don't prove cause.

Numb or tingling fingers — appeared often. People compare the feeling to carpal tunnel, when a wrist nerve is squeezed. Held water could press on that nerve. The reports can't show that CJC-1295 caused the pressure.

The reports may give you questions, but they can't tell you which changes came from the drug.

Which risks remain unknown?

The trials were too small and short to settle these risks. Each concern comes from a related drug, the way growth hormone acts, a public warning, or the drug's unfinished history. None tells you how likely harm is.

• Not approved as care for people. CJC-1295 remains a research drug. Most human proof comes from small early studies. No large trial tested benefit or long-term safety in healthy adults. ^{[1] [14]}

• A possible immune reaction. The FDA considered CJC-1295 for a federal list of drugs that some pharmacies may mix to order. Its advisers said the drug may fool your immune system into attacking it. A review of related drugs did not settle that risk. ^{[18] [13]}

• Could the lasting hormone rise affect cancer risk? IGF-1 is a liver-made hormone tied to growth and repair. The DAC form can keep IGF-1 high for days. Research across large groups links higher levels with a slight rise in some cancers. That IGF-1 link doesn't prove CJC-1295 causes cancer. ^[15]

• Higher blood sugar and weaker insulin action. Growth hormone can make insulin less able to remove sugar from your blood. Researchers also saw this concern with a related drug. It may matter more if blood sugar is already a problem. ^[17]

• Swelling and pressure on nerves. Growth hormone can tell your kidneys to hold salt and water. Puffy hands and tingling like carpal tunnel may follow. Held water may also matter when you have high blood pressure or a weak heart. ^[16]

• A stopped drug program and a reported death. The Phase 2 program was a mid-stage test in people. It enrolled people with HIV who had fat around organs in the belly. That program stopped, and a death was reported during that period. Public records don't show the cause or tie the death to CJC-1295. ^[19]

• Two forms that people confuse. DAC is an added link that lets albumin carry the drug for days. The form without DAC lasts minutes to hours. Mixing up the names hides how long water, sugar, and IGF-1 might be affected. ^{[2] [12]}

• A ban in sport. The world sports anti-doping body bars its use both in and between contests. Lab tests can find it. That sports rule does not answer whether the drug has proved safe. ^[20]

These warnings raise questions, but they can't tell you how likely harm is for you.